This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           December 29, 2014

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store

 


As 2014 comes to a close, the publisher of SGO Women's Cancer News would like to wish its readers, partners and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of SGO Women's Cancer News a look at the most-accessed articles from the year. Our regular publication will resume Jan. 7, 2015.




1. ASTRO issues guideline recommendations for radiation therapy in endometrial cancer
HemOnc Today
From April 30: The American Society for Radiation Oncology recently issued a new guideline, “The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline,” that details the use of adjuvant radiation therapy in the treatment of endometrial cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


2. Pair of pills shows promise for recurrent ovarian cancer
HealthDay News via Philly.com
From June 4: A combination of two new pills may nearly double the length of survival for patients with recurrent ovarian cancer, according to preliminary clinical trial results. The therapy combines the drugs olaparib and cediranib. It provided nearly 18 months of progression-free survival on average, as opposed to nine months' survival with olaparib treatment alone, said Dr. Joyce Liu, a gynecologic oncologist at Dana-Farber Cancer Institute in Boston.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  ChemoFx Improves Ovarian Cancer Outcomes
ChemoFx® provides invaluable information to physicians choosing from 20+ equivalent treatment recommendations without prior knowledge of how individual patients may respond. ChemoFx determines platinum resistance in primary ovarian cancer and demonstrates longer overall survival by 14 months in recurrent ovarian cancer, making it instrumental in improving patient outcomes.
 


3. Should ovaries be removed at the time of hysterectomy?
Medscape (Free login required)
From Sept. 3: A study published in June 2014 issue of Obstetrics Gynecology found that that both hysterectomy alone and hysterectomy with bilateral salpingo-oophorectomy (BSO) are associated with a reduction in cancer risk, especially when performed before 45 years of age. The risk for breast cancer is reduced by both surgical procedures when performed before age 45 years. Hysterectomy with BSO significantly reduces the risk for ovarian cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


4. Doctor's war on a common surgery — morcellation
The Wall Street Journal (Subscription required)
From March 5: Hooman Noorchashm isn't a gynecologist, but his battle against a common — and potentially dangerous — hysterectomy procedure has triggered a heated debate and yielded changes in how it is done. The Harvard-affiliated cardiothoracic surgeon has by all accounts become the driving force trying to curb morcellation, a procedure that may have spread a dangerous form of uterine cancer in his wife.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MISS AN ISSUE OF WOMEN'S CANCER NEWS?
Visit the SGO Women's Cancer News archive page.


5. Debate grows over possible dangers from a type of hysterectomy
The Wall Street Journal (Subscription requried)
From Feb. 5: A British medical journal is the latest voice to enter a growing debate among doctors over a common gynecological procedure that may carry a higher risk of spreading cancer than previously thought. The dispute, detailed in a December Wall Street Journal article, centers on a procedure used in minimally invasive hysterectomies called uterine morcellation. (Article references SGO position statement on morcellation.)
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


6. Most women don't need regular pelvic exams, new guidelines state
HealthDay News via U.S. News and World Report
From July 2: The annual pelvic exam has long been a routine part of women's healthcare, but new guidelines say there's no good reason for it. The recommendations, laid out by the American College of Physicians, advise against pelvic exams for women who aren't pregnant and have no symptoms of a potential problem.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




7. FDA panel approves primary HPV screening tool
The New York Times
From March 19: A federal advisory committee recommended unanimously that a DNA test developed by Roche be approved for use as a primary screening tool. “Has our Pap, as we know it, outlived its time?” Dr. Dorothy Rosenthal testified to the committee. She said deaths from cervical cancer in the United States had stopped declining and that there would be “a tremendous gain” by moving to the new test. The Roche test detects the DNA of human papillomavirus, or HPV, which causes almost all cases of cervical cancer. Pap testing involves examining a cervical sample under the microscope looking for abnormalities.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


8. Current guidelines underestimate US cervical cancer incidence and older women's risk
NBC News
From May 14: Women over age 65, who may believe they no longer need gynecological exams, may be at a much higher risk of cervical cancer than previously believed, researchers reported on Monday. Current guidelines are based on data that don’t take into account the high rate of hysterectomy in the U.S., the team at the University of Maryland School of Medicine found.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


9. Are Pap smears on the way out?
The New York Times
From May 7: Women who want to be screened for cervical cancer have just received a new option — and a new quandary. The venerable Pap smear, which has been the only screening tool to look for cancer in asymptomatic women for many decades, now has a rival, a genetic test that looks for the viruses implicated in causing cervical cancer. Adding a new option seems a positive development. Yet some critics have opposed using the new test as a primary screening tool lest it displace the Pap test, which has been credited with cutting the incidence and death rate from cervical cancer sharply in recent decades.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


10. Ovarian cancer often arises from precursor endometriosis
The Oncology Report
From Oct. 8: Gynecologists, general surgeons and primary care physicians now share an unprecedented opportunity to put a major dent in the incidence of ovarian cancer, according to Dr. Farr R. Nezhat. Mounting evidence suggests that identification and complete surgical removal of endometriosis reduce the risk of several histologic types of ovarian cancer. So when a woman visits her primary care physician for pelvic pain or vaginal bleeding that might be due to endometrial pathology, or a general surgeon finds asymptomatic endometriosis during pelvic surgery, these encounters provide an opportunity for preventive intervention, explained Dr. Nezhat in Lancet Oncology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 



Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Jessica Taylor, Senior Medical Editor, 202-684-7169  
Contribute news


Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Dec. 10, 2014
Mock 2
Mock 2
Dec. 3, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063